Class Action Lawsuit Filed Against Picard Medical, Inc.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2026
0mins
Should l Buy PMI?
Source: Globenewswire
- Class Action Initiation: A class action lawsuit has been filed against Picard Medical for allegedly issuing false statements between September 2 and October 31, 2025, with investors having until April 3, 2026, to seek lead plaintiff status, highlighting serious concerns over the company's transparency and integrity.
- False Promotion Allegations: The complaint alleges that Picard was involved in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals, which artificially inflated stock prices and could lead to significant financial losses for investors.
- Insider Trading Investigation: The lawsuit also claims that insiders or affiliates used offshore accounts to facilitate coordinated share dumping, exacerbating stock price volatility and indicating potential flaws in the company's governance structure.
- Law Firm Credentials: Wolf Haldenstein Adler Freeman & Herz LLP, founded in 1888, boasts over 125 years of experience in securities litigation, dedicated to pursuing justice for investors harmed by misrepresented statements, underscoring its authority in the legal field.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PMI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PMI
About PMI
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Picard Medical, Inc. (PMI) on behalf of investors who purchased securities between September 2 and October 31, 2025, alleging that the company failed to disclose a fraudulent stock promotion scheme involving social media, resulting in significant investor losses.
- Stock Price Crash: On October 24, 2025, Picard's stock price plummeted by 70%, dropping from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00, indicating severe market concerns regarding the company's financial health.
- Investor Rights: Investors must apply by April 3, 2026, to be appointed as lead plaintiffs in the lawsuit, with Bragar Eagel & Squire offering no-cost legal consultations to assist affected investors in understanding their rights and potential remedies.
- Law Firm Overview: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in representing individual and institutional investors in securities, derivative, and commercial litigation, boasting extensive litigation experience and a nationwide practice.
See More
Picard Medical Securities Class Action Notice
- Class Action Timeline: The class action period for Picard Medical, Inc. (NYSE American: PMI) securities runs from September 2, 2025, to October 31, 2025, with a lead plaintiff application deadline set for April 13, 2026, allowing investors to represent others in the litigation.
- Lawsuit Background: The lawsuit alleges that Picard Medical made materially false and misleading statements and failed to disclose significant adverse facts regarding its business and securities trading, which resulted in investor losses and damaged the company's market reputation.
- Choosing Legal Counsel: Investors are encouraged to select qualified legal counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal support and resources in the class action.
- Historical Performance: Rosen Law Firm has recovered over $438 million for investors in 2019 alone and was ranked as a leading firm in securities class actions in 2017, demonstrating its expertise and success in handling such cases.
See More
Class Action Lawsuit Reminder for Picard Medical and Others
- Picard Medical Lawsuit: A class action lawsuit against Picard Medical, Inc. (PMI) alleges that the company made materially false statements between September 2 and October 31, 2025, leading to significant investor losses, with a deadline of April 3, 2026, for investors to apply as lead plaintiffs.
- Plug Power Legal Issues: Plug Power Inc. (PLUG) is facing a class action lawsuit for failing to disclose material facts regarding the availability of funds from a Department of Energy loan between January 17 and November 13, 2025, with the same April 3, 2026, deadline for lead plaintiff applications.
- Richtech Robotics Lawsuit: Richtech Robotics Inc. (RR) is accused of not disclosing its relationship with Microsoft between January 27 and January 29, 2026, resulting in investor losses, and investors must apply by April 3, 2026, to become lead plaintiffs.
- Law Firm Background: Holzer & Holzer, LLC is a top-rated securities litigation law firm that has recovered hundreds of millions for shareholders since its founding in 2000, emphasizing its commitment to vigorous representation of investors in class action lawsuits.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Lawsuit: Richtech Robotics Inc. is facing allegations of making false statements regarding a supposed collaboration with Microsoft during the class period from January 27 to January 29, 2026, which misled investors about the company's prospects and could negatively impact its stock price and legal standing.
- Plug Power Lawsuit: Plug Power, Inc. is accused of overstating the likelihood of receiving funds from a DOE loan during the class period from January 17 to November 13, 2025, potentially forcing the company to pivot to less lucrative projects, thereby undermining investor confidence and market perception.
- Picard Medical Lawsuit: Picard Medical, Inc. is implicated in a fraudulent stock promotion scheme from September 2 to October 31, 2025, failing to disclose insider trading and misinformation, which may lead investors to misjudge the company's financial health and affect shareholder rights.
- BlackRock TCP Capital Lawsuit: BlackRock TCP Capital Corp. is accused of failing to appropriately value investments during the class period from November 6, 2024, to January 23, 2026, resulting in an overstated net asset value, which could raise concerns about the company's financial transparency among investors.
See More
Faruqi & Faruqi Investigates Securities Fraud at Picard Medical
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential securities fraud at Picard Medical, urging investors who purchased securities between September 2 and October 31, 2025, to contact them for legal support to protect their rights.
- Stock Price Plunge: On October 24, 2025, Picard Medical's shares plummeted from $13.20 to $5.31, a drop of $7.89 or 59.8%, marking one of the most significant single-day declines since the company's IPO, which could undermine investor confidence.
- False Promotion Allegations: The complaint alleges that Picard and its executives violated federal securities laws by failing to disclose involvement in a fraudulent stock promotion scheme and insider trading activities, potentially exposing investors to significant losses.
- Class Action Deadline: Faruq & Faruqi reminds investors that the deadline to apply as lead plaintiff in the federal securities class action is April 13, 2026, allowing interested investors to ensure their rights to any potential recovery through legal counsel.
See More
Faruqi & Faruqi Encourages Investors in Picard Medical to Reach Out
- Legal Investigation: Faruq & Faruq LLP is investigating potential claims against Picard Medical, particularly for investors who purchased securities between September 2, 2025, and October 31, 2025, indicating possible legal risks that could undermine shareholder confidence.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly, providing multiple contact options to help them understand their legal rights and take necessary actions.
- Class Action Deadline: Investors should note that the deadline to seek the role of lead plaintiff in the federal securities class action against Picard Medical is April 13, 2026, which may affect their ability to file claims.
- Potential Market Impact: The initiation of this legal investigation could negatively impact Picard Medical's stock price, prompting investors to closely monitor developments to adjust their investment strategies accordingly.
See More
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Picard Medical, Inc. (PMI) on behalf of investors who purchased securities between September 2 and October 31, 2025, alleging that the company failed to disclose a fraudulent stock promotion scheme involving social media, resulting in significant investor losses.
- Stock Price Crash: On October 24, 2025, Picard's stock price plummeted by 70%, dropping from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00, indicating severe market concerns regarding the company's financial health.
- Investor Rights: Investors must apply by April 3, 2026, to be appointed as lead plaintiffs in the lawsuit, with Bragar Eagel & Squire offering no-cost legal consultations to assist affected investors in understanding their rights and potential remedies.
- Law Firm Overview: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in representing individual and institutional investors in securities, derivative, and commercial litigation, boasting extensive litigation experience and a nationwide practice.
See More
Picard Medical Securities Class Action Notice
- Class Action Timeline: The class action period for Picard Medical, Inc. (NYSE American: PMI) securities runs from September 2, 2025, to October 31, 2025, with a lead plaintiff application deadline set for April 13, 2026, allowing investors to represent others in the litigation.
- Lawsuit Background: The lawsuit alleges that Picard Medical made materially false and misleading statements and failed to disclose significant adverse facts regarding its business and securities trading, which resulted in investor losses and damaged the company's market reputation.
- Choosing Legal Counsel: Investors are encouraged to select qualified legal counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal support and resources in the class action.
- Historical Performance: Rosen Law Firm has recovered over $438 million for investors in 2019 alone and was ranked as a leading firm in securities class actions in 2017, demonstrating its expertise and success in handling such cases.
See More
Class Action Lawsuit Reminder for Picard Medical and Others
- Picard Medical Lawsuit: A class action lawsuit against Picard Medical, Inc. (PMI) alleges that the company made materially false statements between September 2 and October 31, 2025, leading to significant investor losses, with a deadline of April 3, 2026, for investors to apply as lead plaintiffs.
- Plug Power Legal Issues: Plug Power Inc. (PLUG) is facing a class action lawsuit for failing to disclose material facts regarding the availability of funds from a Department of Energy loan between January 17 and November 13, 2025, with the same April 3, 2026, deadline for lead plaintiff applications.
- Richtech Robotics Lawsuit: Richtech Robotics Inc. (RR) is accused of not disclosing its relationship with Microsoft between January 27 and January 29, 2026, resulting in investor losses, and investors must apply by April 3, 2026, to become lead plaintiffs.
- Law Firm Background: Holzer & Holzer, LLC is a top-rated securities litigation law firm that has recovered hundreds of millions for shareholders since its founding in 2000, emphasizing its commitment to vigorous representation of investors in class action lawsuits.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Lawsuit: Richtech Robotics Inc. is facing allegations of making false statements regarding a supposed collaboration with Microsoft during the class period from January 27 to January 29, 2026, which misled investors about the company's prospects and could negatively impact its stock price and legal standing.
- Plug Power Lawsuit: Plug Power, Inc. is accused of overstating the likelihood of receiving funds from a DOE loan during the class period from January 17 to November 13, 2025, potentially forcing the company to pivot to less lucrative projects, thereby undermining investor confidence and market perception.
- Picard Medical Lawsuit: Picard Medical, Inc. is implicated in a fraudulent stock promotion scheme from September 2 to October 31, 2025, failing to disclose insider trading and misinformation, which may lead investors to misjudge the company's financial health and affect shareholder rights.
- BlackRock TCP Capital Lawsuit: BlackRock TCP Capital Corp. is accused of failing to appropriately value investments during the class period from November 6, 2024, to January 23, 2026, resulting in an overstated net asset value, which could raise concerns about the company's financial transparency among investors.
See More
Faruqi & Faruqi Investigates Securities Fraud at Picard Medical
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential securities fraud at Picard Medical, urging investors who purchased securities between September 2 and October 31, 2025, to contact them for legal support to protect their rights.
- Stock Price Plunge: On October 24, 2025, Picard Medical's shares plummeted from $13.20 to $5.31, a drop of $7.89 or 59.8%, marking one of the most significant single-day declines since the company's IPO, which could undermine investor confidence.
- False Promotion Allegations: The complaint alleges that Picard and its executives violated federal securities laws by failing to disclose involvement in a fraudulent stock promotion scheme and insider trading activities, potentially exposing investors to significant losses.
- Class Action Deadline: Faruq & Faruqi reminds investors that the deadline to apply as lead plaintiff in the federal securities class action is April 13, 2026, allowing interested investors to ensure their rights to any potential recovery through legal counsel.
See More
Faruqi & Faruqi Encourages Investors in Picard Medical to Reach Out
- Legal Investigation: Faruq & Faruq LLP is investigating potential claims against Picard Medical, particularly for investors who purchased securities between September 2, 2025, and October 31, 2025, indicating possible legal risks that could undermine shareholder confidence.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly, providing multiple contact options to help them understand their legal rights and take necessary actions.
- Class Action Deadline: Investors should note that the deadline to seek the role of lead plaintiff in the federal securities class action against Picard Medical is April 13, 2026, which may affect their ability to file claims.
- Potential Market Impact: The initiation of this legal investigation could negatively impact Picard Medical's stock price, prompting investors to closely monitor developments to adjust their investment strategies accordingly.
See More
